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Abstract. The aim of this retrospective study was to determine the number of dengue fever (DF) and 
dengue hemorrhagic fever (DHF) cases admitted to University Malaya Medical Center (UMMC) in the 
year 2005 together with their clinical presentations and epidemiology. The data for 2005 was collected 
from the medical records department of UMMC. A total of 1,279 cases were admitted in 2005 with DF 
(81%, n=1,040) and DHF (19%, n=239).  January had the greatest number of cases of DF and DHF (22%, 
n=281) and April had the least (4%, n=49). The greatest number of DF cases (38%, n=392) were seen in 
the 20-29 year age group, while the greatest number of DHF cases (32%, n=76) were in the 10-19 year 
age group.  In regard to race, the greatest number of cases were seen in Malays (48%, DF; 49%, DHF). 
Males were more commonly infected than females. The majority of patients infected were students (30%, 
n=385). All patients with DF and DHF presented with fever. The symptoms reported included nausea and 
vomiting, joint pain, gum bleeding and dehydration. The mean value hemoglobin, white blood cell count 
and platelet count were 14.4 g/dl, 4 ×103/dl, 75 ×106/dl, respectively for DF and 15.1 g/dl, 4 ×103/dl, 52 
×106/dl respectively for DHF. The majority of patients were treated with hydration therapy. There were 
three deaths reported, caused by dengue shock syndrome (DSS).
Correspondence: I Jamaiah, Department of 
Parasitology, Faculty of Medicine, University of 
Malaya, 50603 Kuala Lumpur, Malaysia.
E-mail: jamaiah@ummc.edu.my
INTRODUCTION
 Dengue is the most common mosquito-borne 
viral disease of humans that in recent years has 
become a major international public health 
concern. The World Health Organization (WHO) 
estimates that more than 2.5 billion people are at 
risk for dengue infection, and 50 million cases 
occur annually with 22,000 deaths (WHO, 2002). 
The dengue virus is an enveloped single stranded 
RNA virus of the family Flaviridae. There are 
four serotypes which share genetic and antigenic 
features, but infection with one serotype does 
not provide long-term protection against other 
serotypes. The principal vector is the day biting 
Aedes aegypti, which typically breeds in clean 
stagnant water in a wide variety of sites, including 
man-made containers in domestic and peri-
domestic urban areas (Kumarasamy, 2006).
 DF was first reported in Malaysia in 1902 
and DHF in 1962. Since then, epidemics of 
dengue cases have been reported regularly. The 
first major Malaysian epidemic of DHF with 
severe manifestations occurred in 1973, with 969 
reported cases and 54 deaths (Wallace et al, 1980). 
DHF, though endemic in the sixties, emerged as 
a major public health problem in Malaysia from 
1973 onwards (Shekhar and Huat, 1992, 1993). 
Until the end of September 2005, 29,196 cases 
of dengue had been reported with 76 deaths. 
The increasing trend in the incidence of dengue 
infection is a cause for concern (Kumarasamy, 
2006). 
 DF is characterized by fever which lasts from 
5 to 7 days with two or more of the following 
symptoms: headache, retro-orbital pain, myalgia, 
arthralgia, rash, hemorrhagic manifestations, or 
leukopenia.
 DHF is defined as an acute febrile illness with 
hemorrhagic manifestations (shown by a positive 
tourniquet test, petechiae, ecchymoses or purpura, 
or bleeding from the mucosa, gastrointestinal 
tract, injection sites, or other locations), a platelet 
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Fig 1- Age distribution of DF and DHF.
Fig 2- Number of DF and DHF cases by month.
count <100,000/mm3 and objective evidence 
of plasma leakage due to increased vascular 
permeability, shown by either a fluctuation in 
hematocrit ≥20% during the course of illness and 
recovery or clinical signs of plasma leakage, such 
as pleural effusion, ascites, or hypoproteinemia 
(WHO, 1997).
 The main objective of this retrospective 
study was to determine the number of DF and 
DHF cases admitted to the UMMC for the year 
2005 and note their clinical presentations and 
epidemiology.
MATERIALS AND METHODS
 The case records of all patients admitted with 
DF and DHF to the UMMC in the year 2005 were 
reviewed in detail. The data collected included date 
of admission, age, sex, race, nationality, address, 
occupation, clinical presentations, laboratory 
investigation and treatment. Analysis was done 
using SPSS 11 and Microsoft Excel 2003. 
RESULTS
 A total of 1,279 cases were reported at UMMC 
for the year 2005. Eighty-one percent (n=1,040) 
of reported cases was DF and 19% (n=239) were 
DHF, giving a DF to DHF ratio of 4:1. 
 The greatest number of reported cases of DF 
were in the age group of 20-29 years (38%, 329 
cases) and of DHF were in the age group of 10-19 
(32%, 76 cases) (Fig 1). 
 Fig 2 shows the total number of DF and DHF 
cases by month. The greatest number of cases 
were reported in January (22%, n=281); 22% 
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Table 1
Socio-demographic characteristics cases with of DF and DHF.
 Variables DF DHF Total p-value
  n % n % n %
Race Malay 497 48 118 49 615 48 0.813
 Chinese 231 22 49 21 280 22
 Indian 184 18 46 19 230 18
 Others 128 12 26 11 154 12
Sex Male 614 59 148 62 762 60 0.412
 Female 426 41 91 38 517 40
Nationality Malaysian 919 88 213 89 1,132 89 0.741
 Non-Malaysian 121 12 26 11 147 11
Dengue serology result Positive 779 75 204 85 983 77 0.002a
 Negative 121 12 13 6 134 10
 Unknown 140 13 22 9 162 13
a
 Chi-square test is significant at α=0.05 level 
Table 2
Occupations among DF and DHF patients.
Occupation No. %
Student 385 30.1
Factory worker 54 4.2
Housewife 46 3.6
Teacher 22 1.7
Soldier 20 1.6
Restaurant worker 18 1.4
Businessman/woman 18 1.4
Maid 17 1.3
Contractor 17 1.3
Technician 14 1.1
Clerk 14 1.1
Pensioner 13 1.0
General worker 13 1.0
Salesman 12 0.9
(n=231) of the total were DF cases and 21% 
(n=50) were DHF cases. The fewest number of 
dengue cases was reported in April (4%, n=49) 
with 4% (n=44) of the total were DF cases and 
2% (n=5) were DHF cases. 
 Table 1 shows the majority of DF and DHF 
cases were reported among ethnic Malays, males 
and Malaysian citizens. The dengue serology test 
was positive in 77% (n=983). In 13%, the results 
of the dengue serology test were unavailable 
(unknown). 
 All patients with DF and DHF reported fever. 
Nausea and vomiting, joint pain, gum bleeding 
and dehydration were significantly associated 
with DF and DHF (p-value 0.004, 0.043, 0.003, 
and 0.001, respectively) (Table 3).
 Hydration therapy was the commonest 
treatment. Paracetamol was prescribed to all 
patients. Platelet transfusions were given to DHF 
patients when needed. Three patients died due to 
complications of DHF.
 Table 4 shows that the mean (standard 
deviation) hemoglobin, white blood cell count and 
platelet count were 14.4 ± 1.8 g/dl, 4.19 ± 2.87 × 
103/dl, 75.53 ± 50.83 × 106/dl, respectivelyfor DF 
and 15.1 ± 2.0 g/dl, 4.42 ± 2.70 × 103/dl, 51.86 
± 41.01×106/dl for DHF, respectively. However, 
data were missing for platelet count on 2 cases 
and for hemoglobin and white blood cell count 
on 3 cases. 
DISCUSSION
 The ratio of DF:DHF cases for the year 
2005 at UMMC was 4:1. This is lower than 
that reported by the Ministry of Health (MOH), 
Malaysia. The ratio of DF:DHF for years 1996 
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Table 3
Symptoms of DF and DHF.
 Symptoms DHF DF Total p-value
  n % within n % within n % within
   case  case  case
Fever yes 239 100.0 1,040 100.0 1,279 100.0 .a
 no 0 0.0 0 0.0 0 0.0
Myalgia yes 117 49.0 442 42.5 559 43.7 0.710
 no 122 51.0 598 57.5 720 56.3
Headache yes 113 47.3 434 41.7 547 42.8 0.128
 no 126 52.7 606 58.3 732 57.2
Nausea and vomiting yes 183 76.6 696 66.9 879 68.7 0.004b
 no 56 23.4 344 33.1 400 31.3
Petechia yes 62 25.9 200 19.2 262 20.5 0.260
 no 177 74.1 840 80.8 1,017 79.5
Rash yes 80 33.5 353 33.9 433 33.9 0.940
 no 159 66.5 687 66.4 846 66.1
Cough yes 48 20.1 199 19.1 247 19.3 0.717
 no 191 79.9 841 80.9 1,032 80.7
 Abdominal pain yes 101 42.3 272 26.2 373 29.2 0.000b
 no 138 57.7 768 73.8 906 70.8
Joint pain yes 62 25.9 207 19.9 269 21.0 0.043b
 no 177 74.1 833 80.1 1,010 79.0
Gum bleeding yes 61 25.5 176 16.9 237 18.5 0.003b
 no 178 74.5 864 83.1 1,042 81.5
Dehydration yes 94 39.3 297 28.6 391 30.6 0.001b
 no 145 60.7 743 71.4 888 69.4
.a No statistics were computed because fever was a constant.
b Chi-square test is significant at α=0.05 level 
Table 4
Mean hemoglobin, white blood cell count and platelet count.
Cases   Hemoglobin WBC Platelet count
  (g/dl) (x103/dl)  (x106/dl)
DF Mean 14.4 4.19 75.53
  n 1,037 1,037 1,038
  Std deviation 1.8 2.87 50.83
DHF Mean 15.1 4.42 51.86
  n 239 239 239
  Std deviation 2.0 2.70 41.01
Total Mean 14.5 4.23 71.10
  n 1,276 1,276 1,277
  Std deviation 1.8 2.84 49.99
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and 1997 were 26:1 and 23:1, respectively (MOH, 
1996 and 1998). This may be because the area 
covered in this study was small, mostly Selangor 
and Kuala Lumpur, compared to MOH which 
covered all the states of Malaysia. 
 Our study showed the 20-29 years age group 
had the greatest number of cases of DF (38%, 
n=329) and the 10-19 years age group had the 
greatest number of cases of DHF (32%, n=76). 
The MOH for Malaysia also reported similar 
findings. They found the 15-29 year old age 
group had the highest incidence rate for DF 
(MOH, 2000). Fang et al (1984) reported that 
most cases were over age 15 years. These studies 
are different from the epidemics of the 1970s and 
1980s, where the majority of cases were children 
below age 15 years old (Wallace et al, 1980; 
Hussin et al, 2005). DHF is primarily a disease 
of children under 15 years in hyperendemic areas 
(Halstead et al, 2001). 
 January had the greatest number of DF and 
DHF cases with 22% (n=281) while the least 
was in April at 4% (n=49) (Fig 2). Hussin et al 
(2005) also reported similar findings with the 
greatest incidence in January and the least in May. 
Shekhar and Huat (1992-1993) reported a peak 
incidence in August for DHF cases. Wallace et 
al (1980) reported cases occurred mainly from 
May to September. Fang et al (1984) reported the 
majority of cases occurred from July to October. 
The MOH reported the high incidence of dengue 
was probably the result of an increase in breeding 
places at construction sites (MOH, 2000). 
 The cases reported to UMMC showed Malays 
as the most commonly affected ethnic group, 
followed by Chinese, Indians and others. They 
were the most common ethnic group admitted. 
Hussin et al (2005) and Jamaiah et al (2005) 
also reported similar findings. This differs from 
the MOH report that showed Chinese as the 
majority of cases with dengue (43%), followed 
by Malays (39%), and Indians (6.3%) (MOH, 
1996). Shekhar and Huat (1992-1993) reported 
male Chinese as the commonest group affected 
with both DF and DHF. Wallace et al (1980) and 
Fang et al (1984) also reported that most cases 
occurred among Chinese. 
 The majority of DF and DHF patients were 
students (30%, n= 385), followed by factory 
workers (4%, n=54) and housewives (3.6%, 
n=46) (Table 2). This is to be expected as most 
cases occurred in teenagers. 
 All patients (DF and DHF) in this study 
had fever. Hussin et al (2005) and Jamaiah et 
al (2005) also reported fever as the commonest 
symptom. However, according to the WHO, 
the clinical features of DF vary according 
to the age of the patient. Infants and young 
children may have a non-specific febrile illness 
with rash. Older children and adults may have 
either a mild febrile syndrome or the classical 
incapacitating disease, abrupt onset high fever, 
severe headache, pain behind the eyes, muscle 
and joint pains, and rash. DHF is a potentially 
deadly disease that is characterized by high fever, 
hemorrhagic phenomena and circulatory failure. 
The illness commonly begins with a sudden rise in 
temperature accompanied by facial flush and other 
non-specific constitutional symptoms of dengue 
fever. The fever usually continues for two to seven 
days and can be as high as 40-41°C, possibly with 
febrile convulsions and hemorrhagic phenomena 
(WHO, 2002). Petechial skin rash, epistaxis and 
gum bleeding were seen most commonly in mild 
and moderately severe cases of DHF (George and 
Duraisamy, 1981). Wallace et al (1980) reported 
hemorrhagic manifestations were observed in 
67% of cases of DHF in General Hospital Kuala 
Lumpur, Malaysia.
 In this study, there were three deaths. They 
died due to dengue shock syndrome (DSS). 
Mortality can be as high as 10-20% (over 40% 
if shock occurs) without early appropriate 
treatment, but it is as low as 0.2% in hospitals with 
staff experienced with the disease. Warning signs 
that dengue shock syndrome is impending include 
sustained abdominal pain, persistent vomiting, 
change in the level of consciousness (irritability 
or somnolence), a sudden change from fever to 
hypothermia, and a sudden decrease in platelet 
count (Innis, 1995; Rigau-Perez, 1998). 
 The mean value for hemoglobin, white blood 
cell count and platelet count were 14.4 g/dl, 4 
×103 /dl, 75 ×106 /dl, respectively for DF and 15.1 
g/dl, 4 ×103 /dl, 52 ×106 /dl for, respectively DHF 
(Table 4). The mean platelet count for both DF 
and DHF were low compared to the normal value. 
Thrombocytopenia (<100,000/ml) constitutes one 
Vol 38  (suppl 1)  2007 229
dh and dhf at uMMc, MalaySia in 2005
of the most common clinical findings in the course 
of dengue disease (Halstead, 1982; Ramirez-
Ronda and Garcia, 1994). Platelet levels tended 
to decline from a higher value on admission 
to lower levels over subsequent days, with the 
lowest being on day 6 of the fever (Ibrahim and 
Cheong, 1995). The mechanisms involved in 
the thrombocytopenia associated with dengue 
disease are not well known, however, it may be 
due to alterations in megakaryocytopoiesis and 
platelet production. This possibility is based on 
analysis of bone marrow biopsies from dengue 
patients, which demonstrated a decrease in 
marrow cellularity, including megakaryocytes 
(Nelson and Bierman , 1964; Nakao et al, 1989). 
These alterations could be due to the ability of 
dengue virus to infect human hematopoietic cells 
and impair progenitor cell growth (Nakao, 1989; 
Murgue et al, 1997).
 Primary prevention of dengue mainly resides 
in eliminating or reducing the mosquito vector. 
Public spraying for mosquitoes is the most 
important aspect of vector control. Application 
of larvicides, such as Abate®, to standing water is 
more effective in long term control of mosquitoes. 
Initiatives to eradicate pools of standing water 
(such as in flowerpots) have proven useful in 
controlling mosquito borne diseases. Promising 
new techniques have been recently reported from 
Oxford University on rendering Aedes mosquito 
pest sterile (Wikipedia, 2006).
 Personal prevention consists of the use of 
mosquito nets, repellents, cover exposed skin, 
use DEET-impregnated bednets, and avoiding 
endemic areas. This is also important for malaria 
prevention (Wikipedia, 2006). The control of 
dengue outbreaks requires a multi-pronged effort 
by various government agencies (Poovaneswari 
and Lam, 1992).
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